Safety and Efficacy Study of Recombinant Human Lactoferrin to Treat Severe Sepsis
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Kalpalatha K Guntupalli, MD
Baylor College of Medicine
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
34 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Vancouver General Hospital
Vancouver, British Columbia, Canada
- Kingston General Hospital
Kingston, Ontario, Canada
- Centre Hospitalier de Montauban
Montauban, France
- Centre Hospitalier Angouleme
Saint-Michel, France
- Helios Klinikum Erfurt
Erfurt, Germany
- Hospital de Sabadell
Sabadell, Catalonia, Spain
- Hospital Mutua de Terrassa
Terrassa, Catalonia, Spain
- Loma Linda University Medical Center
Loma Linda, California, United States
- Uc Davis Medical Center
Sacramento, California, United States
- Olive View- Ucla Medical Center
Sylmar, California, United States
- Denver Health Medical Center
Denver, Colorado, United States
- the George Washington University Hospital
Washington D.C., District of Columbia, United States
- Rush University Medical Center
Chicago, Illinois, United States
- West Suburban Medical Center
Oak Park, Illinois, United States
- Floyd Memorial Hospital and Health Services
New Albany, Indiana, United States
- University of Iowa Hospitals and Clinic
Iowa City, Iowa, United States
- University of Kansas Medical Center
Kansas City, Kansas, United States
- Baystate Medical Center
Springfield, Massachusetts, United States
- Henry Ford Health System
Detroit, Michigan, United States
- St. John'S Mercy Medical Center
St Louis, Missouri, United States
- St. Louis University
St Louis, Missouri, United States
- Cooper University Hospital
Camden, New Jersey, United States
- Duke University Medical Center
Durham, North Carolina, United States
- Wake Forest University Baptist Medical Center
Winston-Salem, North Carolina, United States
- Wake Forest University Health Sciences
Winston-Salem, North Carolina, United States
- University of Oklahoma Health Science Center
Oklahoma City, Oklahoma, United States
- University of Pittsburgh Medical Center Presbyterian Hospital
Pittsburgh, Pennsylvania, United States
- Rhode Island Hospital
Providence, Rhode Island, United States
- Texas Tech University Health Sciences Center
El Paso, Texas, United States
- Ben Taub General Hospital
Houston, Texas, United States
- the Methodist Hospital
Houston, Texas, United States
- the University of Texas Md Anderson Cancer Center
Houston, Texas, United States
- Scott & White Memorial Hospital
Temple, Texas, United States
- Intermountain Medical Center
Salt Lake City, Utah, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Apr 2008
- Primary completion
- 31 Aug 2009
- Completion
- 28 Feb 2010
- Last update posted
- 23 Aug 2011
- Registered enrollment
- 190
- Registry id
- NCT00630656
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.